 |
|
|
| |
Pharmacokinetics, safety and efficacy of atazanavir, dolutegravir and lamivudine as maintenance regimen in HIV-infected patients: a pilot study
|
| |
| |
Reported by Jules Levin
17th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy, 8-10 June 2016, Washington, DC, USA
PDJ Bollen1,2, R. Van Crevel3, E.H. Gisolf4, M. van Luin5, A. Colbers1, A.E. Brouwer6 and DM Burger1
1 Department of Pharmacy & Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, The Netherlands; 2 Hospital Pharmacy Midden-Brabant, Elisabeth TweeSteden Hospital, Tilburg, The Netherlands; 3 Department of Infectious diseases, Radboud University Medical Center, Nijmegen, The Netherlands; 4 Department of Infectious diseases, Rijnstate Hospital, Arnhem, The Netherlands; 5 Department of Clinical Pharmacy, Rijnstate Hospital, Arnhem, The Netherlands; 6 Department of Infectious diseases, Elisabeth TweeSteden Hospital, Tilburg, The Netherlands.
|
| |
|
|
|
|
|
